Limited evidence for monitoring and treatment of hypophosphataemia in critically ill patients
Federspiel, C.; Itenov, T.S.; Thormar, K.; Bestle, M.H.
Ugeskrift for Laeger 177(50): V07150610
2015
ISSN/ISBN: 1603-6824 PMID: 26651912 Document Number: 684241
Hypophosphataemia is a potentially hazardous metabolic disturbance which is common in critically ill patients. The condition is reported to be associated with severe complications and increased mortality. It is unknown, whether hypophosphataemia has a causal effect or reflects the severity of illness. There are no randomized clinical trials to support treatment of hypophosphataemia with intravenous phosphate substitution, which has resulted in large variations in monitoring and treatment of hypophosphataemia in the intensive care unit.